Targeting immunoproteasome and glutamine supplementation prevent intestinal hyperpermeability

Biochim Biophys Acta Gen Subj. 2017 Jan;1861(1 Pt A):3278-3288. doi: 10.1016/j.bbagen.2016.08.010. Epub 2016 Aug 17.

Abstract

Background: Intestinal hyperpermeability has been reported in several intestinal and non-intestinal disorders. We aimed to investigate the role of the ubiquitin proteasome system in gut barrier regulation in two mice models: the water avoidance stress model (WAS) and a post-inflammatory model (post-TNBS).

Methods: Both models were applied in C57BL/6 male mice (n=7-8/group); Proteasome was targeted by injection of a selective proteasome inhibitor or by using knock-out mice for β2i proteasome subunit. Finally, glutamine supplementation was evaluated.

Results: In both models (WAS at day 10, post-TNBS at day 28), we observed an increase in proteasome trypsin-like activity and in inducible β2/constitutive β2 subunit protein expression ratio, associated with an increase in intestinal permeability. Moreover, intestinal hyperpermeability was blunted by intraperitoneal injection of selective proteasome inhibitor in WAS and post-TNBS mice. Of note, knock-out mice for the β2i subunit exhibited a significant decrease in intestinal permeability and fecal pellet output during WAS. Glutamine supplementation also improved colonic permeability in both models.

Conclusions: In conclusion, the proteasome system is altered in the colonic mucosa of WAS and post-TNBS mice with increased trypsin-like activity. Associated intestinal hyperpermeability was blunted by immunoproteasome inhibition.

Keywords: Glutamine; Intestinal permeability; Post-inflammatory model; Proteasome; Water avoidance stress.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Avoidance Learning / drug effects
  • Colon / drug effects
  • Colon / physiopathology
  • Dietary Supplements*
  • Disease Models, Animal
  • Glutamine / pharmacology*
  • Inflammation / pathology
  • Intestinal Mucosa / drug effects
  • Intestinal Mucosa / pathology
  • Intestinal Mucosa / physiopathology
  • Intestines / drug effects
  • Intestines / pathology
  • Intestines / physiopathology*
  • Male
  • Mice, Inbred C57BL
  • Occludin / metabolism
  • Permeability / drug effects
  • Proteasome Endopeptidase Complex / immunology*
  • Proteasome Endopeptidase Complex / metabolism
  • Proteasome Inhibitors / pharmacology
  • Trinitrobenzenesulfonic Acid

Substances

  • Occludin
  • Proteasome Inhibitors
  • Glutamine
  • Trinitrobenzenesulfonic Acid
  • Proteasome Endopeptidase Complex